Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.46M Buy
59,865
+13,739
+30% +$322K ﹤0.01% 3212
2014
Q2
$1.2M Sell
46,126
-18,646
-29% -$476K ﹤0.01% 3376
2014
Q1
$1.55M Sell
64,772
-44,023
-40% -$927K ﹤0.01% 3032
2013
Q4
$2.13M Buy
108,795
+17,385
+19% +$350K ﹤0.01% 2735
2013
Q3
$1.93M Sell
91,410
-99,262
-52% -$2.17M ﹤0.01% 2626
2013
Q2
$4.2M Buy
+190,672
New +$4.62M 0.01% 1806

Other funds holding EXC

UBS's EXC Position: Q3 2014 in Review

UBS increased its Exelon (EXC) stake by 29% in Q3 2014, buying an estimated $12.2M and bringing the position to 2,309,944 shares worth $56.2M. The position accounts for 0.04% of the portfolio, ranked #463.

UBS first reported a position in EXC in Q2 2013 and has held it in 6 quarters since. 700 funds tracked by Wall St. Rank hold EXC as of Q3 2014.

  • UBS held 2,309,944 shares of Exelon worth $56.2M as of Q3 2014.
  • UBS bought 521,591 Exelon shares in Q3 2014, an estimated $12.2M.
  • Exelon made up 0.04% of UBS's portfolio in Q3 2014, its #463 holding.
  • UBS first reported a position in Exelon in Q2 2013 and has held it in 6 quarters since.
  • 700 funds tracked by Wall St. Rank held Exelon as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.